Shareholding for the Period Ended June 30, 2016
Merck Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2016. For more details, kindly Click here15-07-2016
15-07-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016
Merck Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.12-07-2016
Board Meeting Intimation for Results
Merck Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 25, 2016, to consider and approve the un-audited financial results for the quarter ended June 30, 2016.07-07-2016
Updates on Outcome of AGM
Merck Ltd has submitted to BSE a copy of the minutes of the 49th Annual General Meeting of the Company held on June 10, 2016.07-07-2016
Shareholding for the Period Ended March 31, 2016
Merck Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here22-06-2016
Closure of Trading Window
Merck Ltd has informed BSE that the Company has already issued notification to its employees on June 10, 2016 regarding closure of trading window for them for the purposes of consideration and approval of the un-audited financial results from June 16, 2016 until 24 hours from the publication of the un-audited financial results for the quarter to be ended on June 30, 2016. The Company would be subsequently informing the date of the Board Meeting for...16-06-2016
Updates on Outcome of AGM
Merck Ltd has submitted to BSE a copy of proceedings of the 49th Annual General Meeting of the Company held on June 10, 2016.13-06-2016
Merck, Pfizer double size of diabetes drug study to catch rivals
The pharmaceutical companies are developing the drug ertugliflozin for use alone and in combination with Merck's best-selling Januvia11-06-2016
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Merck Ltd has informed BSE regarding the details of Voting results at the 49th Annual General Meeting (AGM) of the Company held on June 10, 2016, under Regulation 44(3) of SEBI (LODR) Regulations, 2015.11-06-2016
Standalone Financial Results, Limited Review Report for March 31, 2016
Merck Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Standalone Limited Review for the period ended March 31, 201612-05-2016